Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02310152 · ClinicalTrials.gov registry record · NA
Explanatory Clinical Trial of a Novel Parent Intervention for Childhood Anxiety (SPACE)
A NA study of Anxiety Disorders and Phobic Disorders, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 124
- Enrollment target
- 1
- Study location
NCT02310152: Completed NA study of Anxiety Disorders and Phobic Disorders, sponsored by Yale University.
NCT02310152 is a NA study of Anxiety Disorders and Phobic Disorders that has completed, run by Yale University. The registered enrollment target is 124 participants, below the 1,138-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02310152, a NA study of Anxiety Disorders and Phobic Disorders, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 124 participants
- Enrollment target
- 1
- Study location
Study Summary
Childhood anxiety disorders are very common, carry tremendous personal and societal costs, frequently do not respond adequately to treatment, and involving parents in treatment has so far not enhanced outcomes. Explanatory clinical trials are needed to identify parent specific mechanisms of change that are not targeted in direct child treatment, and to identify markers of who is most likely to benefit from parent intervention. This study is an explanatory clinical trial of a parent based intervention and of cognitive behavioral therapy, and an investigation of biological and behavioral moderators of treatment response.
Primary Outcome
Clinician determined rating of illness
Conditions Studied
Interventions
- BEHAVIORAL CBT
- BEHAVIORAL Parent-Based Treatment of Child and Adolescent Anxiety Disorders
Study Locations (1)
Connecticut
- Yale University Child Study Center - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2014-11 |
| Est. Completion | 2018-11 |
| Phase | NA |
What the finished NCT02310152 record still lists
NCT02310152 is an interventional study that assigns participants to a tested intervention. The registered 124 participants enrollment target is mid-sized for trials with a published cap, below the 1,138-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (89% lower).
The record links to 3 conditions, with Anxiety Disorders appearing as the primary indexed condition, and to 2 interventions - of which CBT is the first listed.
NCT02310152 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT02310152 about?
NCT02310152 is a clinical study titled "Explanatory Clinical Trial of a Novel Parent Intervention for Childhood Anxiety (SPACE)". Childhood anxiety disorders are very common, carry tremendous personal and societal costs, frequently do not respond adequately to treatment, and involving parents in treatment has so far not enhanced outcomes. Explanatory clinical trials are needed to identify parent specific mechanisms of change t...
What is the current status of trial NCT02310152?
This trial is currently completed. It is a NA study. The enrollment target is 124 participants. The study started on 2014-11. Estimated completion is 2018-11.
What conditions does trial NCT02310152 study?
This clinical trial studies the following conditions: Anxiety Disorders, Phobic Disorders, Anxiety, Separation.
What interventions are being tested in trial NCT02310152?
The interventions under investigation include: CBT (BEHAVIORAL), Parent-Based Treatment of Child and Adolescent Anxiety Disorders (BEHAVIORAL).
Who is sponsoring clinical trial NCT02310152?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02310152 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02310152's enrollment target sits among peer trials
124 38th of 84 higher than 47 of 84 other Anxiety Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
-
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
RECRUITING · NA
-
Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population
RECRUITING · NA
-
Managing Anxiety in Pediatric Primary Care (MAPP)
RECRUITING · NA
-
DINO RCT - Treating Anxiety in Children With Autism
RECRUITING · NA
-
Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523014 · 124 participants · Phase 2
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- NCT02670707 · 124 participants · Phase 3
Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
- NCT02830724 · 124 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
- NCT04748809 · 124 participants · NA
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia